Advanced search
Publication Cover
Cancer Biology & Therapy Volume 16, 2015 - Issue 11
Submit an article Journal homepage
1,501
Views
14
CrossRef citations to date
0
Altmetric
Clinical Study

Cost-effectiveness of RAS screening before monoclonal antibodies therapy in metastatic colorectal cancer based on FIRE3 Study

Feng WenDepartment of Medical Oncology; Cancer Center; State Key Laboratory of Biotherapy; West China Hospital; Sichuan University; Chengdu, China;West China Biostatistics and Cost-Benefit Analysis Center; Sichuan University; Chengdu, China; These authors contributed equally to this work.
,
Yu YangDepartment of Medical Oncology; Cancer Center; State Key Laboratory of Biotherapy; West China Hospital; Sichuan University; Chengdu, China;West China Biostatistics and Cost-Benefit Analysis Center; Sichuan University; Chengdu, China; These authors contributed equally to this work.
,
Pengfei ZhangDepartment of Medical Oncology; Cancer Center; State Key Laboratory of Biotherapy; West China Hospital; Sichuan University; Chengdu, China;West China Biostatistics and Cost-Benefit Analysis Center; Sichuan University; Chengdu, China
,
Jian ZhangDepartment of Medical Oncology; Cancer Center; State Key Laboratory of Biotherapy; West China Hospital; Sichuan University; Chengdu, China;West China Biostatistics and Cost-Benefit Analysis Center; Sichuan University; Chengdu, China
,
Jing ZhouDepartment of Medical Oncology; Cancer Center; State Key Laboratory of Biotherapy; West China Hospital; Sichuan University; Chengdu, China;West China Biostatistics and Cost-Benefit Analysis Center; Sichuan University; Chengdu, China
,
Ruilei TangDepartment of Medical Oncology; Cancer Center; State Key Laboratory of Biotherapy; West China Hospital; Sichuan University; Chengdu, China;West China Biostatistics and Cost-Benefit Analysis Center; Sichuan University; Chengdu, China
,
Hongdou ChenDepartment of Medical Oncology; Cancer Center; State Key Laboratory of Biotherapy; West China Hospital; Sichuan University; Chengdu, China;West China Biostatistics and Cost-Benefit Analysis Center; Sichuan University; Chengdu, China
,
Hanrui ZhengWest China Biostatistics and Cost-Benefit Analysis Center; Sichuan University; Chengdu, China;Department of Clinical Pharmacy; West China Hospital; Sichuan University; Chengdu, China
,
Ping FuWest China Biostatistics and Cost-Benefit Analysis Center; Sichuan University; Chengdu, China;Division of Nephrology of Department of Internal Medicine; West China Hospital; Sichuan University; Chengdu, China
&
Qiu LiDepartment of Medical Oncology; Cancer Center; State Key Laboratory of Biotherapy; West China Hospital; Sichuan University; Chengdu, China;West China Biostatistics and Cost-Benefit Analysis Center; Sichuan University; Chengdu, ChinaCorrespondence[email protected]
 show all
Pages 1577-1584 | Received 01 Apr 2015, Accepted 12 Sep 2015, Published online: 04 Nov 2015

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.